Neuralink human trial
  • Neuralink is a brain implant startup founded by Elon Musk.
  • The company is valued at approximately  $5 billion.
  • The law enforcement arm of the U.S Department of Agriculture has been investing Neuralink for potential animal-welfare violations.

Neuralink, Elon Musk’s brain-implant startup said it has received approval to begin recruitment for the first human trial for its brain implant for paralysis patients.

The trial, which is slated to take an initial six years, is intended to test tech designed by the company. People being targeted are quadriplegic patients with vertical spinal cord injury or ALS who are over the age of 22.

Neuralink has previously come under scrutiny over the company’s treatment of monkeys in testing while also being under investigation for illegally transporting pathogen-laced devices removed from the monkeys by the Department of Transportation.

In May, the company said it had received clearance from the FDA for its first-in-human clinical trial.

The company has said the initial goal of the study is to enable people to control a computer cursor or keyboard using their thoughts alone.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Hold my beer: UK pub group implements Uber’s dynamic pricing strategy

British pubs have been facing headwinds contributed by high inflation in recent…

The cost of serviced apartments in Europe might fall

The latest market update from specialized booking agency SilverDoor suggests that serviced…

Navigating Kenya’s E-Logistics Landscape: Lessons from Sendy’s Closure

Kamal Budhabatti, Craft Silicon’s Group CEO, highlights the prevalent trend in Kenya’s…

7 Ways to Ramp Up Your Email Marketing Efforts

Email marketing remains a powerful tool for businesses to connect with their…